Literature DB >> 8441680

Structure of the rat p53 tumor suppressor gene.

J E Hulla1, R P Schneider.   

Abstract

Aberration within the p53 tumor suppressor gene is the most frequently identified genetic damage in human cancer. Regulatory functions proposed for the p53 protein include modulation of the cell cycle, cellular differentiation, signal transduction, and gene expression. Additionally, the p53 gene product may guard the genome against incorporation of damaged DNA. To facilitate study of its role in carcinogenesis using a common animal model, we determined the structure of the rat p53 gene. We identified 18 splice sites and defined 25 bases of the intervening sequences adjacent to these sites. We also discovered an allelic polymorphism that occurs within intron 5 of the gene. The rat gene approximates the mouse ortholog. It is 12 kb in length with the non-coding exon 1 separated from exon 2 by 6.2 kb of intervening sequence. The location and size of all rat gene introns approximate those of the mouse. Whereas the mouse and human genes each contain 11 exons, the rat p53 gene is composed of only 10. No intervening sequence occurs between the region of the rat gene corresponding to exons 6 and 7 of the mouse and human p53 genes. This implies intron 6 may be functionally insignificant for species in which it is retained. To extrapolate to p53 involvement in human tumorigenesis, we suggest that mutational events within intron 6 may not be of pathological significance unless splicing is hindered.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8441680      PMCID: PMC309173          DOI: 10.1093/nar/21.3.713

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  31 in total

Review 1.  p53 mutations: gains or losses?

Authors:  D Michalovitz; O Halevy; M Oren
Journal:  J Cell Biochem       Date:  1991-01       Impact factor: 4.429

2.  Cellular localization and cell cycle regulation by a temperature-sensitive p53 protein.

Authors:  J Martinez; I Georgoff; J Martinez; A J Levine
Journal:  Genes Dev       Date:  1991-02       Impact factor: 11.361

Review 3.  Structural aspects of the p53 protein in relation to gene evolution.

Authors:  T Soussi; C Caron de Fromentel; P May
Journal:  Oncogene       Date:  1990-07       Impact factor: 9.867

4.  Nucleotide sequence of a cDNA encoding the rat p53 nuclear oncoprotein.

Authors:  T Soussi; C Caron de Fromentel; C Breugnot; E May
Journal:  Nucleic Acids Res       Date:  1988-12-09       Impact factor: 16.971

Review 5.  The p53 cellular tumor antigen: gene structure, expression and protein properties.

Authors:  M Oren
Journal:  Biochim Biophys Acta       Date:  1985-11-12

6.  Mutations in the p53 gene occur in diverse human tumour types.

Authors:  J M Nigro; S J Baker; A C Preisinger; J M Jessup; R Hostetter; K Cleary; S H Bigner; N Davidson; S Baylin; P Devilee
Journal:  Nature       Date:  1989-12-07       Impact factor: 49.962

7.  The gene and the pseudogene for mouse p53 cellular tumor antigen are located on different chromosomes.

Authors:  H H Czosnek; B Bienz; D Givol; R Zakut-Houri; D D Pravtcheva; F H Ruddle; M Oren
Journal:  Mol Cell Biol       Date:  1984-08       Impact factor: 4.272

8.  The rat genome contains a p53 pseudogene: detection of a processed pseudogene using PCR.

Authors:  J E Hulla
Journal:  PCR Methods Appl       Date:  1992-05

9.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

10.  Analysis of the gene coding for the murine cellular tumour antigen p53.

Authors:  B Bienz; R Zakut-Houri; D Givol; M Oren
Journal:  EMBO J       Date:  1984-09       Impact factor: 11.598

View more
  14 in total

1.  Truncated N-terminal mutants of SV40 large T antigen as minimal immortalizing agents for CNS cells.

Authors:  William J Freed; Peisu Zhang; Joseph F Sanchez; Ora Dillon-Carter; Mark Coggiano; Stacie L Errico; Brian D Lewis; Mary Ellen Truckenmiller
Journal:  Exp Neurol       Date:  2005-02       Impact factor: 5.330

2.  Linkage mapping of the rat Tp53 gene on chromosome 10.

Authors:  F Canzian; T Ushijima; M Toyota; T Sugimura; M Nagao
Journal:  Mamm Genome       Date:  1996-08       Impact factor: 2.957

3.  Distribution of the p53 pseudogene among mouse species and subspecies.

Authors:  H Tanooka; A Ootsuyama; T Shiroishi; K Moriwaki
Journal:  Mamm Genome       Date:  1995-05       Impact factor: 2.957

4.  p53 accumulation in polynuclear-giant-cells.

Authors:  T Wiethege; B Voss; K M Müller
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

5.  Exon-specific DNA hypomethylation of the p53 gene of rat colon induced by dimethylhydrazine. Modulation by dietary folate.

Authors:  Y I Kim; I P Pogribny; R N Salomon; S W Choi; D E Smith; S J James; J B Mason
Journal:  Am J Pathol       Date:  1996-10       Impact factor: 4.307

Review 6.  Regucalcin and cell regulation: role as a suppressor protein in signal transduction.

Authors:  Masayoshi Yamaguchi
Journal:  Mol Cell Biochem       Date:  2011-03-24       Impact factor: 3.396

7.  Species- and tissue-specific expression of the C-terminal alternatively spliced form of the tumor suppressor p53.

Authors:  K Will; G Warnecke; S Bergmann; W Deppert
Journal:  Nucleic Acids Res       Date:  1995-10-25       Impact factor: 16.971

8.  A virilized patient with congenital hemihypertrophy.

Authors:  S Mark; O H Clark; R A Kaplan
Journal:  Postgrad Med J       Date:  1994-10       Impact factor: 2.401

Review 9.  Suppressive role of regucalcin in liver cell proliferation: involvement in carcinogenesis.

Authors:  M Yamaguchi
Journal:  Cell Prolif       Date:  2013-06       Impact factor: 6.831

10.  Potential role of p53 mutation in chemical hepatocarcinogenesis of rats.

Authors:  Wei-Guo Deng; Yan Fu; Yu-Lin Li; Toshihiro Sugiyama
Journal:  World J Gastroenterol       Date:  2004-01       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.